Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc > Rapid Tests

<< Previous

Bullboard Posts

Next >>

Comment by Hfxroseon Nov 25, 2020 1:40pm

278 Views

Post# 31970967

RE:RE:RE:RE:RE:RE:RE:Rapid Tests

Health Canada is reviewing 8 rapid antigen tests in total. Only 2 are Canadian companies, the rest are from the US, Germany, China, Korea. If you do a little research these details are easy to find. Not sure what you mean by dozens? But if you go on the Health Canada website you can see all of these details and the countries of origin for the tests. The US does not have dozens of rapid antigen test manufactures.

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading